Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation ADAM22_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-13299 | ADAM22 | up-regulates | NRF1 | activates | R-488 | 22 | 3 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-13301 | ADAM22 | down-regulates | LMX1B | represses | R-2929 | 11 | 1 | Drugs (17) Regulator Drugs (0)Regulon Drugs (17)BEVACIZUMAB, CONBERCEPT, AMG-780, MEDI-3617, PEGAPTANIB SODIUM, ENIBARCIMAB, TREBANANIB, PEGAPTANIB OCTASODIUM, MUPARFOSTAT, VANUCIZUMAB, RANIBIZUMAB, FARICIMAB, CVX-060, ABICIPAR PEGOL, NESVACUMAB, AFLIBERCEPT, BROLUCIZUMAB |
CMF-13303 | ADAM22 | up-regulates | NR5A2 | activates | R-3773 | 3 | 1 | Drugs (5) Regulator Drugs (0)Regulon Drugs (5)BINTRAFUSP ALFA, LUSPATERCEPT, FRESOLIMUMAB, OCRIPLASMIN, LY-2382770 |
CMF-13306 | ADAM22 | up-regulates | MZF1 | activates | R-1018 | 16 | 1 | Drugs (12) Regulator Drugs (0)Regulon Drugs (12)BEVACIZUMAB, CONBERCEPT, PEGAPTANIB SODIUM, ENIBARCIMAB, PEGAPTANIB OCTASODIUM, MUPARFOSTAT, VANUCIZUMAB, RANIBIZUMAB, FARICIMAB, ABICIPAR PEGOL, AFLIBERCEPT, BROLUCIZUMAB |